"10.1371_journal.pone.0071795","plos one","2013-08-13T00:00:00Z","Yijung Yang; Jung-Hwa Tao-Cheng; K Ulrich Bayer; Thomas S Reese; Ayse Dosemeci","Laboratory of Neurobiology, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland, United States of America; EM Facility, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland, United States of America; Department of Pharmacology, University of Colorado Denver School of Medicine, Aurora, Colorado, United States of America","Conceived and designed the experiments: AD YY JHTC. Performed the experiments: YY JHTC. Analyzed the data: AD YY JHTC. Contributed reagents/materials/analysis tools: KUB. Wrote the paper: YY JHTC KUB TR AD.","The University of Colorado is currently seeking patent protection for tatCN21, its derivatives, and its uses (PCT/US08/077934 “Compositions and methods for improved CaMKII inhibitors and uses thereof”). This does not alter the authors’ adherence to all the PLOS ONE policies on sharing data and materials.","2013","08","Yijung Yang","YY",5,TRUE,3,2,3,5,TRUE,TRUE,FALSE,0,NA,FALSE
